Well done.
I wanted more at that price but had money tied up in other stocks. The usual if I sell then they move.
Happy to have a parcel on LDX. I won't even consider selling before 31c, but by that stage I might have to reassess the company and direction related to the market. Was up last night doing various calcs and forming a theoretical case depending on profit margins, uptake and reach of just FebriDx.
I started at $1 then quickly calculated $5 mc, then when factoring in their initial report of saving the US medical system $2.5 billion each year in direct medical costs, I realised this could be way higher than that like $15+.
These valuations of course take time with revenue and profit margins showing genuine market direction which will be over the next year or two, so I don't want to get ahead of myself.
Exciting to be on board nonetheless.
A genuine device with real world impact on a growing concern with antibiotic resistance and a way to potentially help reduce that and help reduce the burden on medical system costs related to less revisits and more timely and efficient outpatient care is all a benefit to society if it works out as initially reported.
GLTAH
Add to My Watchlist
What is My Watchlist?
